Patients Stopping Weight-Loss Medications Gain Back Pounds Far More Rapidly Compared to Dieters

A recent study reveals that individuals who come off new weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.

Findings released in a prominent medical journal points out that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"People using these medications should be informed of the potential of fast rebound weight gain when the therapy ends," warns researcher Dr. Susan Jebb.

Such speed of regain implies a reversion to pre-treatment mass in about 18 months.

Analyzing Treatments

The research, which reviewed 37 of trials involving thousands of patients, contrasted the results of the injectable medications with other pills.

The team emphasize that people who shed pounds through dieting usually experience a slower creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Quick Regain

Doctors suggest the mode of action of the jabs accounts for the accelerated rebound.

The injections imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' results in appetite is unsuppressed, making overeating much more probable."

A Chronic Disease?

Health authorities suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians say that, given the significant potential of weight regain, the treatment is often long-term.

This perspective is echoed by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," akin to managing conditions like hypertension.

Patient Testimonies

Individuals who have come off the jabs report a intense resurgence of hunger.

"It was like a switch flipping and you're instantly starving," described an individual.

The struggle is worsened if individuals have not adopted sustainable dietary or behavioural changes during therapy.

Growing Adoption

Figures suggest that millions of people in the UK have tried these injections in the last 12 months, with interest being substantial.

• Use is higher among women compared to men.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private prescriptions rather than public health services.

Finally, researchers emphasize that while these medications are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on ongoing lifestyle support.